Renishaw partnership demonstrates AM capabilities for spinal implants

Global engineering company Renishaw has collaborated with two advanced technology companies to demonstrate the advantages of additive manufacturing (AM) in the production of spinal implants. By working with Irish Manufacturing Research (IMR) and nTopology, the project shows how streamlined the transition from design to AM can be when working with the right partners.

Spinal implant in model

Manufacturing research organisation IMR designed a representative titanium spinal implant, aimed at the cervical spine (c spine), using advanced manufacturing software company nTopology’s generative design software. IMR then manufactured the implants using Renishaw’s RenAM 500M metal AM system.

AM can be used to manufacture spinal implants with lattice structures, which cannot be achieved with conventional manufacturing techniques. An implant with a lattice structure is lightweight, can be optimised to meet the required loading conditions and has a greater surface area, which can aid osseointegration. Therefore, AM implants can be designed to mimic the mechanical properties of bone, resulting in better patient outcomes. But all of this comes to nothing if you do not have the tools to create the design.”

Ed Littlewood, Marketing Manager of Renishaw’s Medical and Dental Products Division

Traditional CAD tools weren’t built to design complex lattice structures; the job would be difficult or even impossible. Topology was designed to complement existing workflows and make the job easier. We cut the design time of complex structures from days to minutes which was a crucial component in helping this project run to schedule.”

Matt Rohr, nTopology’s Application Engineering Manager

Renishaw worked tirelessly with us on improving the AM process for producing the spinal implants. Together, we designed a set of experiments that yield the most appropriate parameter settings for the product. As a result, we reduced the amount of post processing required on key features of the implants by a factor of ten.”

Sean McConnell, Senior Research Engineer at IMR

Patients with medical conditions including degenerative disc disease, herniated disc, spondylolisthesis, spinal stenosis and osteoporosis can require spinal implants to restore intervertebral height. The improved implant design made possible by AM means patients may require shorter surgery time and fewer revision surgeries, saving healthcare resources and costs.

Renishaw also uses its AM machines to produce healthcare products, such as craniomaxillofacial implants and dental frameworks, at its site in Miskin, South Wales.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Renishaw plc - Spectroscopy. (2019, June 19). Renishaw partnership demonstrates AM capabilities for spinal implants. News-Medical. Retrieved on December 22, 2024 from https://www.news-medical.net/news/20190305/Renishaw-partnership-demonstrates-AM-capabilities-for-spinal-implants.aspx.

  • MLA

    Renishaw plc - Spectroscopy. "Renishaw partnership demonstrates AM capabilities for spinal implants". News-Medical. 22 December 2024. <https://www.news-medical.net/news/20190305/Renishaw-partnership-demonstrates-AM-capabilities-for-spinal-implants.aspx>.

  • Chicago

    Renishaw plc - Spectroscopy. "Renishaw partnership demonstrates AM capabilities for spinal implants". News-Medical. https://www.news-medical.net/news/20190305/Renishaw-partnership-demonstrates-AM-capabilities-for-spinal-implants.aspx. (accessed December 22, 2024).

  • Harvard

    Renishaw plc - Spectroscopy. 2019. Renishaw partnership demonstrates AM capabilities for spinal implants. News-Medical, viewed 22 December 2024, https://www.news-medical.net/news/20190305/Renishaw-partnership-demonstrates-AM-capabilities-for-spinal-implants.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New drug delivery system by Renishaw hopes to aid Parkinson’s treatment